JP2017522007A - フィトケミカル強化水 - Google Patents
フィトケミカル強化水 Download PDFInfo
- Publication number
- JP2017522007A JP2017522007A JP2016570073A JP2016570073A JP2017522007A JP 2017522007 A JP2017522007 A JP 2017522007A JP 2016570073 A JP2016570073 A JP 2016570073A JP 2016570073 A JP2016570073 A JP 2016570073A JP 2017522007 A JP2017522007 A JP 2017522007A
- Authority
- JP
- Japan
- Prior art keywords
- fluid
- bacopa
- water
- combination
- ground
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000017807 phytochemicals Nutrition 0.000 title claims abstract description 52
- 229930000223 plant secondary metabolite Natural products 0.000 title claims abstract description 52
- 235000020535 bottled fortified water Nutrition 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 68
- 239000012530 fluid Substances 0.000 claims abstract description 67
- 238000000034 method Methods 0.000 claims abstract description 36
- 238000000605 extraction Methods 0.000 claims abstract description 17
- 238000003860 storage Methods 0.000 claims abstract description 17
- 241000196324 Embryophyta Species 0.000 claims description 120
- 235000015418 Bacopa monnieria Nutrition 0.000 claims description 91
- 239000000284 extract Substances 0.000 claims description 25
- WZWPYJOPCULCLQ-UHFFFAOYSA-N Bacopaside II Chemical compound C12C(O)(C)C(C=C(C)C)COC2(OC2)CC2(C2(CCC3C4(C)C)C)C1CCC2C3(C)CCC4OC(C1OC2C(C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O WZWPYJOPCULCLQ-UHFFFAOYSA-N 0.000 claims description 22
- 241000167550 Centella Species 0.000 claims description 20
- ZOFQVMPJZHCDBS-UHFFFAOYSA-N bacopasaponin C Natural products C12C(O)(C)C(C=C(C)C)COC2(OC2)CC2(C2(CCC3C4(C)C)C)C1CCC2C3(C)CCC4OC(C1OC2C(C(O)C(CO)O2)O)OCC(O)C1OC1OC(CO)C(O)C(O)C1O ZOFQVMPJZHCDBS-UHFFFAOYSA-N 0.000 claims description 13
- RANQPHKSRUUPKK-GPUGMLHBSA-N bacopaside x Chemical compound O([C@H]1[C@@H](O)CO[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@H]4[C@H]5[C@@](C)(O)C[C@@H](O[C@]55OC[C@]4(C5)[C@]3(C)CC[C@H]2C1(C)C)C=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RANQPHKSRUUPKK-GPUGMLHBSA-N 0.000 claims description 12
- CDEVGTJBRPBOPH-UHFFFAOYSA-N bacopaside A3 Natural products CC1(C)C2CCC3(C)C4(C5)COC65OC(C=C(C)C)CC(C)(O)C6C4CCC3C2(C)CCC1OC(C1OC2C(C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O CDEVGTJBRPBOPH-UHFFFAOYSA-N 0.000 claims description 11
- 235000010755 mineral Nutrition 0.000 claims description 11
- 239000011707 mineral Substances 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 11
- CDEVGTJBRPBOPH-HYIRPWBFSA-N Bacoside A3 Natural products O([C@@H]1[C@@H](O[C@@H]2[C@@H](O)[C@@H](O)[C@H](CO)O2)[C@@H](O[C@H]2C(C)(C)[C@@H]3[C@@](C)([C@H]4[C@](C)([C@]56[C@H]([C@H]7[C@@](O)(C)C[C@@H](/C=C(\C)/C)O[C@@]7(OC5)C6)CC4)CC3)CC2)O[C@@H](CO)[C@H]1O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](CO)O1 CDEVGTJBRPBOPH-HYIRPWBFSA-N 0.000 claims description 10
- CDEVGTJBRPBOPH-CYGCIDRFSA-N chembl447375 Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@H]4[C@@H]5[C@@](C)(O)C[C@@H](O[C@]55OC[C@]4(C5)[C@]3(C)CC[C@H]2C1(C)C)C=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CDEVGTJBRPBOPH-CYGCIDRFSA-N 0.000 claims description 10
- 239000011734 sodium Substances 0.000 claims description 10
- 239000011575 calcium Substances 0.000 claims description 8
- 229910052791 calcium Inorganic materials 0.000 claims description 8
- 239000000796 flavoring agent Substances 0.000 claims description 8
- 235000019634 flavors Nutrition 0.000 claims description 8
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 8
- 229910052700 potassium Inorganic materials 0.000 claims description 8
- 229910052708 sodium Inorganic materials 0.000 claims description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 7
- 239000011591 potassium Substances 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 6
- 235000021311 artificial sweeteners Nutrition 0.000 claims description 5
- 239000011777 magnesium Substances 0.000 claims description 5
- 229910052749 magnesium Inorganic materials 0.000 claims description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 4
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 claims description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 4
- 239000008122 artificial sweetener Substances 0.000 claims description 4
- 239000000835 fiber Substances 0.000 claims description 4
- 235000021096 natural sweeteners Nutrition 0.000 claims description 4
- 230000001737 promoting effect Effects 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 235000013599 spices Nutrition 0.000 claims description 4
- -1 steviastecioside Chemical compound 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- RMLYXMMBIZLGAQ-UHFFFAOYSA-N (-)-monatin Natural products C1=CC=C2C(CC(O)(CC(N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-UHFFFAOYSA-N 0.000 claims description 2
- RMLYXMMBIZLGAQ-HZMBPMFUSA-N (2s,4s)-4-amino-2-hydroxy-2-(1h-indol-3-ylmethyl)pentanedioic acid Chemical compound C1=CC=C2C(C[C@](O)(C[C@H](N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-HZMBPMFUSA-N 0.000 claims description 2
- NUFKRGBSZPCGQB-FLBSXDLDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;pentahydrate Chemical compound O.O.O.O.O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C NUFKRGBSZPCGQB-FLBSXDLDSA-N 0.000 claims description 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims description 2
- 239000004377 Alitame Substances 0.000 claims description 2
- 108010011485 Aspartame Proteins 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- 239000004386 Erythritol Substances 0.000 claims description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- 229920001202 Inulin Polymers 0.000 claims description 2
- 239000005913 Maltodextrin Substances 0.000 claims description 2
- 229920002774 Maltodextrin Polymers 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- 101710084933 Miraculin Proteins 0.000 claims description 2
- 241000204052 Neotermes Species 0.000 claims description 2
- 239000004376 Sucralose Substances 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 244000269722 Thea sinensis Species 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 235000019409 alitame Nutrition 0.000 claims description 2
- 108010009985 alitame Proteins 0.000 claims description 2
- 239000000605 aspartame Substances 0.000 claims description 2
- 235000010357 aspartame Nutrition 0.000 claims description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 2
- 229960003438 aspartame Drugs 0.000 claims description 2
- 235000021028 berry Nutrition 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 239000001569 carbon dioxide Substances 0.000 claims description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 2
- 239000008373 coffee flavor Substances 0.000 claims description 2
- 108010010165 curculin Proteins 0.000 claims description 2
- 229940109275 cyclamate Drugs 0.000 claims description 2
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 claims description 2
- 239000008121 dextrose Substances 0.000 claims description 2
- 235000019414 erythritol Nutrition 0.000 claims description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 2
- 229940009714 erythritol Drugs 0.000 claims description 2
- 239000008369 fruit flavor Substances 0.000 claims description 2
- 235000012907 honey Nutrition 0.000 claims description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 2
- 229940029339 inulin Drugs 0.000 claims description 2
- 239000000905 isomalt Substances 0.000 claims description 2
- 235000010439 isomalt Nutrition 0.000 claims description 2
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims description 2
- 239000000832 lactitol Substances 0.000 claims description 2
- 235000010448 lactitol Nutrition 0.000 claims description 2
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims description 2
- 229960003451 lactitol Drugs 0.000 claims description 2
- 229940035034 maltodextrin Drugs 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 229930189775 mogroside Natural products 0.000 claims description 2
- 235000019204 saccharin Nutrition 0.000 claims description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims description 2
- 229940081974 saccharin Drugs 0.000 claims description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 claims description 2
- 229960001462 sodium cyclamate Drugs 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 235000019408 sucralose Nutrition 0.000 claims description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 241000295198 Bacopa Species 0.000 claims 17
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 claims 4
- 229910021589 Copper(I) bromide Inorganic materials 0.000 claims 2
- 229910021591 Copper(I) chloride Inorganic materials 0.000 claims 2
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 claims 2
- LKDRXBCSQODPBY-OEXCPVAWSA-N D-tagatose Chemical compound OCC1(O)OC[C@@H](O)[C@H](O)[C@@H]1O LKDRXBCSQODPBY-OEXCPVAWSA-N 0.000 claims 1
- 235000013325 dietary fiber Nutrition 0.000 claims 1
- 239000002304 perfume Substances 0.000 claims 1
- 238000005728 strengthening Methods 0.000 claims 1
- 235000012206 bottled water Nutrition 0.000 abstract description 12
- 239000000203 mixture Substances 0.000 abstract description 8
- 235000020188 drinking water Nutrition 0.000 abstract description 6
- 239000003651 drinking water Substances 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 229930193652 Bacoside Natural products 0.000 abstract description 5
- 230000003078 antioxidant effect Effects 0.000 abstract description 4
- 230000007407 health benefit Effects 0.000 abstract description 4
- 229930190519 bacopaside Natural products 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 240000002999 Bacopa monnieri Species 0.000 description 71
- 239000000463 material Substances 0.000 description 48
- 244000146462 Centella asiatica Species 0.000 description 40
- 235000004032 Centella asiatica Nutrition 0.000 description 38
- 229930182490 saponin Natural products 0.000 description 25
- 235000017709 saponins Nutrition 0.000 description 25
- 150000007949 saponins Chemical class 0.000 description 25
- 230000004083 survival effect Effects 0.000 description 19
- 239000003814 drug Substances 0.000 description 15
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 229930003935 flavonoid Natural products 0.000 description 11
- 150000002215 flavonoids Chemical class 0.000 description 11
- 235000017173 flavonoids Nutrition 0.000 description 11
- 229940079593 drug Drugs 0.000 description 10
- 230000036541 health Effects 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 8
- 230000035899 viability Effects 0.000 description 8
- 235000013361 beverage Nutrition 0.000 description 7
- 230000003247 decreasing effect Effects 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 244000187129 Bacopa monnieria Species 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000008399 tap water Substances 0.000 description 6
- 241000282412 Homo Species 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 238000007876 drug discovery Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 235000020679 tap water Nutrition 0.000 description 5
- 238000003466 welding Methods 0.000 description 5
- PBRJTYBOSTVXGS-UHFFFAOYSA-N Bacopaside C Chemical compound O1CC(O)(COC(=O)C=2C=CC(O)=CC=2)C(O)C1OC1C(O)C(O)C(CO)OC1OCCC1=CC=CC=C1 PBRJTYBOSTVXGS-UHFFFAOYSA-N 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 229960000890 hydrocortisone Drugs 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 208000024827 Alzheimer disease Diseases 0.000 description 3
- 229930182558 Sterol Natural products 0.000 description 3
- 239000012675 alcoholic extract Substances 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 3
- 229930184882 bacopasaponin Natural products 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000003925 brain function Effects 0.000 description 3
- 210000003169 central nervous system Anatomy 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 230000002124 endocrine Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 238000012552 review Methods 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- 244000089069 Bacopa floribunda Species 0.000 description 2
- YMACEWFCLOFSBZ-UHFFFAOYSA-N Bacopaside IV Chemical compound CC1(C)C2CCC3(C)C4(C5)COC65OC(C=C(C)C)CC(C)(O)C6C4CCC3C2(C)CCC1OC(C1O)OCC(O)C1OC1OC(CO)C(O)C(O)C1O YMACEWFCLOFSBZ-UHFFFAOYSA-N 0.000 description 2
- RJDSARTZFIBDAR-UHFFFAOYSA-N Bacopaside V Chemical compound C12C(O)(C)C(C=C(C)C)COC2(OC2)CC2(C2(CCC3C4(C)C)C)C1CCC2C3(C)CCC4OC(C1O)OCC(O)C1OC1OC(CO)C(O)C(O)C1O RJDSARTZFIBDAR-UHFFFAOYSA-N 0.000 description 2
- GKLLCNWAEBKYGL-UHFFFAOYSA-N Bacoside B Natural products CC(=CCC(C)(O)C1C2CCC3C(C)(CCC4C(C)(C)C(CCC34CO)OC5C(O)C(O)C(OCC6OCC(O)C(O)C6O)OC5CO)C2(C)CC1=O)C GKLLCNWAEBKYGL-UHFFFAOYSA-N 0.000 description 2
- LKCTWIIDXXXXAR-CYGHALRTSA-N Bacoside a Chemical compound CC(C)=CCC[C@](C)(O)[C@@H]1[C@H]2CC[C@H]3[C@@](C)(CC[C@H]4C(C)(C)C(CC[C@]34CO)O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4OC[C@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@]2(C)CC1=O LKCTWIIDXXXXAR-CYGHALRTSA-N 0.000 description 2
- 240000004784 Cymbopogon citratus Species 0.000 description 2
- 235000017897 Cymbopogon citratus Nutrition 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 102000012004 Ghrelin Human genes 0.000 description 2
- 101800001586 Ghrelin Proteins 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 235000006439 Lemna minor Nutrition 0.000 description 2
- 244000207740 Lemna minor Species 0.000 description 2
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 206010029333 Neurosis Diseases 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 206010033307 Overweight Diseases 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 206010000059 abdominal discomfort Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 229930002877 anthocyanin Natural products 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 239000004410 anthocyanin Substances 0.000 description 2
- 150000004636 anthocyanins Chemical class 0.000 description 2
- 229930002878 anthoxanthin Natural products 0.000 description 2
- 150000004637 anthoxanthins Chemical class 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000001773 anti-convulsant effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000002249 anxiolytic agent Substances 0.000 description 2
- JXSVIVRDWWRQRT-UYDOISQJSA-N asiatic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C JXSVIVRDWWRQRT-UYDOISQJSA-N 0.000 description 2
- LBGFKBYMNRAMFC-PYSQTNCISA-N asiatic acid Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@]2(C)[C@H]1C)C(=O)O LBGFKBYMNRAMFC-PYSQTNCISA-N 0.000 description 2
- 229940011658 asiatic acid Drugs 0.000 description 2
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 2
- 229940022757 asiaticoside Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000003293 cardioprotective effect Effects 0.000 description 2
- 230000001149 cognitive effect Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- CLXOLTFMHAXJST-UHFFFAOYSA-N esculentic acid Natural products C12CC=C3C4CC(C)(C(O)=O)CCC4(C(O)=O)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(CO)C CLXOLTFMHAXJST-UHFFFAOYSA-N 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- GNKDKYIHGQKHHM-RJKLHVOGSA-N ghrelin Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)COC(=O)CCCCCCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CC=CC=C1 GNKDKYIHGQKHHM-RJKLHVOGSA-N 0.000 description 2
- 150000002338 glycosides Chemical group 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 208000002551 irritable bowel syndrome Diseases 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 230000000926 neurological effect Effects 0.000 description 2
- 230000000324 neuroprotective effect Effects 0.000 description 2
- 208000015238 neurotic disease Diseases 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000008635 plant growth Effects 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000003938 response to stress Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000000527 sonication Methods 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000002438 stress hormone Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000002349 well water Substances 0.000 description 2
- 235000020681 well water Nutrition 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- INLFWQCRAJUDCR-IQVMEADQSA-N (1R,2S,4S,5'S,6R,7S,8R,9S,12S,13S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane] Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CCCCC4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 INLFWQCRAJUDCR-IQVMEADQSA-N 0.000 description 1
- ZOFQVMPJZHCDBS-MUUHSGPCSA-N 26fg38011g Chemical compound O([C@H]1[C@@H](O)CO[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@H]4[C@]5([C@@]3(CC[C@H]2C1(C)C)C)C[C@]1(OC5)OC[C@H]([C@]([C@@H]14)(C)O)C=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZOFQVMPJZHCDBS-MUUHSGPCSA-N 0.000 description 1
- RANQPHKSRUUPKK-UHFFFAOYSA-N 3-O-[alpha-L-arabinofuranosyl-(1->2)-O-{beta-D-glucopyranosyl-(1->3)}-(alpha-L-arabinopyranosyl)]jujubogenin Natural products CC(C)=CC1CC(C)(O)C2C3CCC4C5(C)CCC(OC6OCC(O)C(OC7OC(CO)C(O)C(O)C7O)C6OC6OC(CO)C(O)C6O)C(C)(C)C5CCC4(C)C33COC2(C3)O1 RANQPHKSRUUPKK-UHFFFAOYSA-N 0.000 description 1
- SKFWOYHZBNAJGA-UHFFFAOYSA-N 3-O-[alpha-L-arabinofuranosyl-(1->2)-{6-O-sulfonyl-beta-D-glucopyranosyl-(1->3)}-(alpha-L-arabinopyranosyl)]pseudojujubogenin Natural products C12C(O)(C)C(C=C(C)C)COC2(OC2)CC2(C2(CCC3C4(C)C)C)C1CCC2C3(C)CCC4OC(C1OC2C(C(O)C(CO)O2)O)OCC(O)C1OC1OC(COS(O)(=O)=O)C(O)C(O)C1O SKFWOYHZBNAJGA-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- BTXWEVPGWQEJKI-UHFFFAOYSA-N Bacopaside I Natural products CC(=CC1COC23CC4(CO2)C(CCC5C6(C)CCC(OC7OCC(O)C(OC8OC(COS(=O)(=O)O)C(O)C(O)C8OC9OCC(O)C(O)C9O)C7O)C(C)(C)C6CCC45C)C3C1(C)O)C BTXWEVPGWQEJKI-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 101100421200 Caenorhabditis elegans sep-1 gene Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241001584859 Colocasia <moth> Species 0.000 description 1
- 244000205754 Colocasia esculenta Species 0.000 description 1
- 235000006481 Colocasia esculenta Nutrition 0.000 description 1
- 244000016281 Cymbalaria muralis Species 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 241000959048 Gratiola Species 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 235000015916 Hydrocotyle vulgaris Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- BNMGUJRJUUDLHW-HCZMHFOYSA-N Madecassoside Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(C[C@@H](O)[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O BNMGUJRJUUDLHW-HCZMHFOYSA-N 0.000 description 1
- BNMGUJRJUUDLHW-HLUHVYOBSA-N Madecassoside Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5[C@H](O)C[C@@]34C)[C@@H]2[C@H]1C)C(=O)O[C@@H]6O[C@H](CO[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O BNMGUJRJUUDLHW-HLUHVYOBSA-N 0.000 description 1
- 240000007948 Mecardonia procumbens Species 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 206010027439 Metal poisoning Diseases 0.000 description 1
- 235000017879 Nasturtium officinale Nutrition 0.000 description 1
- 240000005407 Nasturtium officinale Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 241000209490 Nymphaea Species 0.000 description 1
- 235000016791 Nymphaea odorata subsp odorata Nutrition 0.000 description 1
- 235000000365 Oenanthe javanica Nutrition 0.000 description 1
- 240000006243 Oenanthe sarmentosa Species 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 244000117865 Polygonum odoratum Species 0.000 description 1
- 235000018656 Polygonum odoratum Nutrition 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 229930185210 Saponoside Natural products 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000004338 Syringa vulgaris Nutrition 0.000 description 1
- 244000297179 Syringa vulgaris Species 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 241000233948 Typha Species 0.000 description 1
- 240000000260 Typha latifolia Species 0.000 description 1
- 208000025609 Urogenital disease Diseases 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 208000000558 Varicose Ulcer Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000005083 Zinc sulfide Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000001887 anti-feedant effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003091 anti-genotoxic effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000000949 anxiolytic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000002012 ayurvedic medicine Substances 0.000 description 1
- SKFWOYHZBNAJGA-DKZUISOASA-N bacopaside i Chemical compound O([C@H]1[C@@H](O)CO[C@@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@H]4[C@@]5([C@@]3(CC[C@H]2C1(C)C)C)C[C@]1(OC5)OC[C@H]([C@]([C@@H]14)(C)O)C=C(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]1O SKFWOYHZBNAJGA-DKZUISOASA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000020123 bottled water type Nutrition 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000036995 brain health Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000006999 cognitive decline Effects 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 230000007370 cognitive improvement Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008753 endothelial function Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000021321 essential mineral Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- QOLIPNRNLBQTAU-UHFFFAOYSA-N flavan Chemical class C1CC2=CC=CC=C2OC1C1=CC=CC=C1 QOLIPNRNLBQTAU-UHFFFAOYSA-N 0.000 description 1
- 150000002206 flavan-3-ols Chemical class 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 150000002214 flavonoid derivatives Chemical class 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000020509 fortified beverage Nutrition 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 239000003673 groundwater Substances 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- 239000008233 hard water Substances 0.000 description 1
- 208000010501 heavy metal poisoning Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 244000038280 herbivores Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000031146 intracellular signal transduction Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- PRAUVHZJPXOEIF-AOLYGAPISA-N madecassic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2[C@H](O)C[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C PRAUVHZJPXOEIF-AOLYGAPISA-N 0.000 description 1
- BUWCHLVSSFQLPN-UHFFFAOYSA-N madecassic acid Natural products CC1CCC2(CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(C5CCC34C)C(=O)O)C2C1C)C(=O)OC6OC(COC7OC(CO)C(OC8OC(C)C(O)C(O)C8O)C(O)C7O)C(O)C(O)C6O BUWCHLVSSFQLPN-UHFFFAOYSA-N 0.000 description 1
- 229940011656 madecassic acid Drugs 0.000 description 1
- 229940090813 madecassoside Drugs 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 238000010197 meta-analysis Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000001962 neuropharmacologic effect Effects 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002898 organic sulfur compounds Chemical class 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- ALAGDBVXZZADSN-UHFFFAOYSA-N pentazine Chemical compound C1=NN=NN=N1 ALAGDBVXZZADSN-UHFFFAOYSA-N 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000008638 plant developmental process Effects 0.000 description 1
- 230000008636 plant growth process Effects 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- FJWLWIRHZOHPIY-UHFFFAOYSA-N potassium;hydroiodide Chemical compound [K].I FJWLWIRHZOHPIY-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000000476 thermogenic effect Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052984 zinc sulfide Inorganic materials 0.000 description 1
- DRDVZXDWVBGGMH-UHFFFAOYSA-N zinc;sulfide Chemical compound [S-2].[Zn+2] DRDVZXDWVBGGMH-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/30—Treatment of water, waste water, or sewage by irradiation
- C02F1/32—Treatment of water, waste water, or sewage by irradiation with ultraviolet light
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/44—Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis
- C02F1/444—Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis by ultrafiltration or microfiltration
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/72—Treatment of water, waste water, or sewage by oxidation
- C02F1/78—Treatment of water, waste water, or sewage by oxidation with ozone
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/1578—Calcium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/16—Potassium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/1614—Sodium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2132—Other phenolic compounds, polyphenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Hydrology & Water Resources (AREA)
- Water Supply & Treatment (AREA)
- Environmental & Geological Engineering (AREA)
- Physiology (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
Claims (28)
- フィトケミカル強化流体の調製方法であって、
バコパ、センテラ、又はそれらを合わせたものの地上部分又は葉の部分を得る工程と、
少なくとも微量の無機物を有する流体を得る工程と、
前記微量の無機物は、少なくともナトリウム、カルシウム、及びカリウムであり、
前記流体はpHが5.5或いはそれよりも大きく、
前記バコパ、センテラ、又はそれらを合わせたものの地上部分又は葉の部分を前記流体内に置き、抽出流体を形成する工程と、
前記抽出流体を約1.7℃で少なくとも2週間保存する工程と
を含む方法。 - 前記バコパ又はセンテラの地上部分は、枝の頂点から8〜10cmのところで回収される、請求項1の方法。
- 前記抽出流体は1.7℃で保存される、請求項1の方法。
- 前記抽出流体はpH7〜7.8である、請求項1の方法。
- 前記抽出流体はpH7又はpH7.8である、請求項4の方法。
- 前記バコパ又はセンテラ又はそれらを合わせたものの地上部分又は葉の部分は、流体100ml当たり1〜4gで加えられる、請求項1の方法。
- 前記抽出流体は、バコパ、センテラ、又はそれらを合わせたものからバコサイドA3を抽出し、前記バコサイドA3は水100ml当たり0.43〜0.56mgの値を有する、請求項1の方法。
- 前記抽出流体は、バコパ、センテラ、又はそれらを合わせたものからバコパシドIIを抽出し、前記バコパシドIIは水100ml当たり2.0〜2.43mgの値を有する、請求項1の方法。
- 前記抽出流体は、バコパ、センテラ、又はそれらを合わせたものからバコパシドXを抽出し、前記バコパシドXは水100ml当たり0.32〜0.81mgの値を有する、請求項1の方法。
- 前記抽出流体は、バコパ、センテラ、又はそれらを合わせたものからバコサポリンCを抽出し、前記バコサポリンCは水100ml当たり0.72〜0.96mgの値を有する、請求項1の方法。
- 前記抽出流体又は流体に食物繊維を加える工程を更に含む、請求項1の方法。
- 前記抽出流体又は流体に香料を加える工程を更に含む、請求項1の方法。
- 前記香料は、ベリー風味、果物風味、香辛料風味、コーヒー風味、紅茶風味、ビタミン、無機物、繊維、香辛料、スクラロース、アスパラテーム、デキストロースアスパラテミンとマルトデキシトリンの結合物、サイクラメイト、サッカリン、ネオターム、アセフルテームカリウム、アリテーム、サイクラミン酸ナトリウム、グリシン、D-タガトース、モグロシド、ステビアステシオシド、サクロース、マンニトール、ブラゼイン、クルクリン、エリトリトール、グリセロール、クリクルヒジン、イヌリン、イソマルト、ラクチトール、ミラクリン、モナチン、モネリン、ペンタジン、ソルビトール、サウマイン、キシリトール、蜂蜜を含む、請求項12の方法。
- 人工甘味料の濃度は、1×105〜2×101g/Lであり、天然甘味料の濃度は、1.46×101Mである、請求項12の方法。
- 前記微量の無機物は無機塩により供給され、前記無機塩は、CaCl2、NaCl、MgCl2、VCl、KCl、 CrCl、MnCl2、CoCl、CuCl、ZuCl2、MoCl、SeCl、CaSO4、Na2SO4、MgSO4、VSO4、KSO4、Cr2SO4、MnSO4、CoSO4、Cu2SO4、ZnSO4、MO2SO4、SeSO4、CaI2、NaI、MgI2、VI、KI、CrI、MnI2、CoI、CuI、ZnI2、MoI、SeI、CaBr2、NaBr、MgBr2、VBr、KBr、CrBr、MnBr2、CoBr、CuBr、ZuBr2、MoBr、SeBrである、請求項1の方法。
- 前記無機塩は、1×101mg/L〜2×102 mg/Lで加えられる、請求項15の方法。
- 前記無機塩は少なくとも1個の食餌無機物を供給し、前記食餌無機物は、2 mg/L〜20 mg/Lのカルシウムと、4 mg/L〜15 mg/Lのマグネシウムと、5 mg/L〜20 mg/Lのナトリウムと、0.2 mg/L〜6.0 mg/Lのカリウムと、5 mg/L〜15 mg/Lの塩化物と、100 mg/L〜200 mg/Lの重炭酸塩である、請求項16の方法。
- 前記抽出流体に炭酸ガスを入れる工程を更に含む、請求項1の方法。
- 少なくとも1個の加工済フィトケミカル源を付加することによりフィトケミカル値を上げる工程を更に含み、
前記加工済フィトケミカル源は、粉末状バコパ、粉末状センテラ、粉末状バコパ地上植物部分、粉末状センテラ地上植物部分、バコパ水抽出物、センテラ水抽出物、バコパアルコール抽出物、センテラアルコール抽出物、乾燥バコパ地上植物部分、乾燥センテラ地上植物部分である
請求項1の方法。 - 前記流体と、バコパ、センテラ、或いはそれらを合わせたものの地上部分又は葉の部分を保存容器に置く工程を更に含み、
均質化装置を前記保存容器に載置し、前記均質化装置は電気式ブレンダ、機械式ブレンダ、又は超音波破砕装置であり、
前記電気式ブレンダは更に、
前記保存容器に回転可能に固定される均質化装置の刃と、
前記均質化装置の刃の回転軸に沿って載置される電気モータと、
前記電気モータと電気的に連通する電源と、
前記電源から前記電気モータへの電流を制御するように適合させられるスイッチ、トグルスイッチ、瞬時スイッチ又はボタンを含み、
前記機械式ブレンダは更に、
前記保存容器に回転可能に固定される均質化装置の刃と、
外部源からの機械的入力を受け入れるように適合されるハンドクランク又はシャフトを含み、
前記超音波破砕装置は更に、
超音波バー又はフォークと、
前記超音波バー又はフォークと電気的に連通する電源と、
前記電源から前記超音波バー又はフォークへの電流を制御するように適合されるスイッチ、トグルスイッチ、瞬時スイッチ又はボタンを含む
請求項1の方法。 - 薬用植物のフィトケミケル生成促進方法であって、
バコパ、センテラ、又はそれらを合わせたものの少なくとも地上部分又は葉の部分を得る工程と、
少なくとも微量の無機物を有する流体を得る工程と、
前記微量の無機塩は少なくともナトリウム、カルシウム、及びカリウムであり、
前記流体はpHが5.5又はそれよりも高く、
前記バコパ、センテラ、又はそれらを合わせたものの地上部分又は葉の部分を前記流体に入れて、抽出流体を形成する工程と、
前記抽出流体を約1.7℃で少なくとも2週間保存する工程と
を含む方法。 - 前記抽出流体は1.7℃で保存される、請求項21の方法。
- 前記抽出流体は、pHが7〜7.8である、請求項21の方法。
- 前記抽出流体は、pHが7又は7.8である、請求項23の方法。
- 前記バコパ、センテラ、又はそれらを合わせたものの地上部分又は葉の部分は、流体100ml当たり1g〜4gが加えられる、請求項21の方法。
- 前記微量の無機物は無機塩により供給され、前記無機塩は、CaCl2、NaCl、MgCl2、VCl、KCl、 CrCl、MnCl2、CoCl、CuCl、ZuCl2、MoCl、SeCl、CaSO4、Na2SO4、MgSO4、VSO4、KSO4、Cr2SO4、MnSO4、CoSO4、Cu2SO4、ZnSO4、MO2SO4、SeSO4、CaI2、NaI、MgI2、VI、KI、CrI、MnI2、CoI、CuI、ZnI2、MoI、SeI、CaBr2、NaBr、MgBr2、VBr、KBr、CrBr、MnBr2、CoBr、CuBr、ZuBr2、MoBr、又はSeBrである、請求項21の方法。
- 前記無機塩は1×101mg/L〜2×102 mg/Lで加えられる、請求項26の方法。
- 前記無機塩は少なくとも1個の食餌無機物を供給し、前記食餌無機物は、2 mg/L〜20 mg/Lのカルシウムと、4 mg/L〜15 mg/Lのマグネシウムと、5 mg/L〜20 mg/Lのナトリウムと、0.2 mg/L〜6.0 mg/Lのカリウムと、5 mg/L〜15 mg/Lの塩化物と、100 mg/L〜200 mg/Lの重炭酸塩である、請求項27の方法。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2014/040489 WO2015187120A1 (en) | 2014-06-02 | 2014-06-02 | Phytochemical enhanced water |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017522007A true JP2017522007A (ja) | 2017-08-10 |
JP6444434B2 JP6444434B2 (ja) | 2018-12-26 |
Family
ID=54767068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016570073A Active JP6444434B2 (ja) | 2014-06-02 | 2014-06-02 | フィトケミカル強化水 |
Country Status (12)
Country | Link |
---|---|
US (1) | US10918688B2 (ja) |
EP (1) | EP3148351B1 (ja) |
JP (1) | JP6444434B2 (ja) |
CN (1) | CN106659200B (ja) |
AU (1) | AU2014396209B2 (ja) |
CA (1) | CA2950113C (ja) |
ES (1) | ES2914673T3 (ja) |
IL (1) | IL249318B (ja) |
MX (1) | MX2016015848A (ja) |
PL (1) | PL3148351T3 (ja) |
RU (1) | RU2647901C1 (ja) |
WO (1) | WO2015187120A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI702913B (zh) * | 2018-11-15 | 2020-09-01 | 泓發樂活氏水科技服務股份有限公司 | 一種調製飲品的方法、水濃縮液及其飲品 |
US11617381B2 (en) * | 2020-06-26 | 2023-04-04 | The Coca-Cola Company | Systems and methods for bottling still flavored water |
CN113511568A (zh) * | 2021-05-24 | 2021-10-19 | 张美洁 | 一种防止病毒交叉感染的医疗疾控装置 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6342789A (ja) * | 1986-08-07 | 1988-02-23 | Toshio Masuda | 活性化水 |
JPH05178750A (ja) * | 1990-07-17 | 1993-07-20 | Lab Andromaco Sa | 組織修復促進活性をもつ天然オリゴ糖の製造法 |
JPH05344825A (ja) * | 1991-04-08 | 1993-12-27 | Toshiyuki Ota | 植物の保存法 |
JPH0678631A (ja) * | 1992-09-04 | 1994-03-22 | Sanyo Electric Co Ltd | バラの切り花の貯蔵方法 |
JP2007295907A (ja) * | 2006-04-27 | 2007-11-15 | Sky International:Kk | コタラヒンブツを含有する健康食品 |
JP2008074785A (ja) * | 2006-09-22 | 2008-04-03 | Asahi Breweries Ltd | 脳機能改善組成物 |
US20080132455A1 (en) * | 2005-05-03 | 2008-06-05 | Raju Gokaraju Ganga | Process For Producing Enriched Fractions Containing Up To 100% Of Bacopasaponins From The Plant Materials Of Bacopa Species |
JP2010508821A (ja) * | 2006-11-02 | 2010-03-25 | ザ・コカ−コーラ・カンパニー | フィトエストロゲンを有する高甘味度甘味料組成物及びこれにより甘味を付与された組成物 |
US20120145628A1 (en) * | 2009-08-02 | 2012-06-14 | Yeal Ben Zvi | Phytoremediation for desalinated water post-processing |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6261565B1 (en) * | 1996-03-13 | 2001-07-17 | Archer Daniels Midland Company | Method of preparing and using isoflavones |
AUPP254598A0 (en) * | 1998-03-23 | 1998-04-23 | Quality Wheat Crc Limited | Food colouring and method for producing same |
DE20122059U1 (de) * | 2001-02-14 | 2004-04-01 | Stanglmeier, Udo | Neuartiger verdauungsfördernder Fruchtwein aus Myrobalan-Steinfrüchten |
DE10106748A1 (de) * | 2001-02-14 | 2002-09-05 | Udo Stanglmeier | Verfahren zur Frischhaltung und Geschmacksverbesserung von Myrobalanen (Steinfrüchte von Terminalia edulis, chebula, bellerica u. a.) zur Nutzbarmachung für Nahrungsergänzungszwecke |
US7273626B2 (en) * | 2002-12-13 | 2007-09-25 | Dubey Gobind Prasad | Herbal preparation for management of cardiovascular and neurologic disorders |
CN1433974A (zh) * | 2003-03-08 | 2003-08-06 | 黄美凤 | 生物免疫调控健康饮水及其生产方法 |
US9265808B2 (en) * | 2004-03-23 | 2016-02-23 | Lifeline Nutraceuticals Corporation | Compositions for alleviating inflammation and oxidative stress in a mammal |
US20050209445A1 (en) | 2004-11-30 | 2005-09-22 | Gokaraju Ganga R | Process for producing enriched fractions containing upto 100% of bacoside a and bacoside b from plant materials of bacopa species |
US7923041B2 (en) * | 2005-02-03 | 2011-04-12 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
GB0909318D0 (en) * | 2009-06-01 | 2009-07-15 | Univ Nac Del Litoral | Methods and compositions for stress tolerance in plants |
KR101103589B1 (ko) * | 2009-09-03 | 2012-01-09 | 단국대학교 산학협력단 | 파이토케미컬 함량이 증가되고, 항산화능이 향상된 모시대 추출물의 제조방법 |
AU2012363349B2 (en) * | 2012-01-01 | 2016-11-10 | Botanical Water Technologies Ip Ltd | Plant based beverages, and methods for preparation thereof |
WO2013183065A2 (en) * | 2012-06-06 | 2013-12-12 | Ramaswamy Rajendran | Extraction of phytochemicals from plant matter |
-
2014
- 2014-06-02 MX MX2016015848A patent/MX2016015848A/es unknown
- 2014-06-02 AU AU2014396209A patent/AU2014396209B2/en active Active
- 2014-06-02 RU RU2016147221A patent/RU2647901C1/ru not_active IP Right Cessation
- 2014-06-02 CN CN201480079517.2A patent/CN106659200B/zh active Active
- 2014-06-02 ES ES14893706T patent/ES2914673T3/es active Active
- 2014-06-02 WO PCT/US2014/040489 patent/WO2015187120A1/en active Application Filing
- 2014-06-02 PL PL14893706T patent/PL3148351T3/pl unknown
- 2014-06-02 CA CA2950113A patent/CA2950113C/en active Active
- 2014-06-02 JP JP2016570073A patent/JP6444434B2/ja active Active
- 2014-06-02 EP EP14893706.3A patent/EP3148351B1/en active Active
-
2015
- 2015-09-09 US US14/848,372 patent/US10918688B2/en active Active
-
2016
- 2016-11-30 IL IL249318A patent/IL249318B/en active IP Right Grant
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6342789A (ja) * | 1986-08-07 | 1988-02-23 | Toshio Masuda | 活性化水 |
JPH05178750A (ja) * | 1990-07-17 | 1993-07-20 | Lab Andromaco Sa | 組織修復促進活性をもつ天然オリゴ糖の製造法 |
JPH05344825A (ja) * | 1991-04-08 | 1993-12-27 | Toshiyuki Ota | 植物の保存法 |
JPH0678631A (ja) * | 1992-09-04 | 1994-03-22 | Sanyo Electric Co Ltd | バラの切り花の貯蔵方法 |
US20080132455A1 (en) * | 2005-05-03 | 2008-06-05 | Raju Gokaraju Ganga | Process For Producing Enriched Fractions Containing Up To 100% Of Bacopasaponins From The Plant Materials Of Bacopa Species |
JP2007295907A (ja) * | 2006-04-27 | 2007-11-15 | Sky International:Kk | コタラヒンブツを含有する健康食品 |
JP2008074785A (ja) * | 2006-09-22 | 2008-04-03 | Asahi Breweries Ltd | 脳機能改善組成物 |
JP2010508821A (ja) * | 2006-11-02 | 2010-03-25 | ザ・コカ−コーラ・カンパニー | フィトエストロゲンを有する高甘味度甘味料組成物及びこれにより甘味を付与された組成物 |
US20120145628A1 (en) * | 2009-08-02 | 2012-06-14 | Yeal Ben Zvi | Phytoremediation for desalinated water post-processing |
Non-Patent Citations (1)
Title |
---|
ミネラル成分・硬度の比較一覧, JPN6018010338, ISSN: 0003762944 * |
Also Published As
Publication number | Publication date |
---|---|
EP3148351A4 (en) | 2018-01-10 |
AU2014396209B2 (en) | 2018-03-29 |
EP3148351A1 (en) | 2017-04-05 |
AU2014396209A1 (en) | 2016-12-22 |
US10918688B2 (en) | 2021-02-16 |
CN106659200A (zh) | 2017-05-10 |
IL249318A0 (en) | 2017-02-28 |
CA2950113C (en) | 2021-05-18 |
PL3148351T3 (pl) | 2022-06-06 |
IL249318B (en) | 2019-07-31 |
JP6444434B2 (ja) | 2018-12-26 |
RU2647901C1 (ru) | 2018-03-21 |
US20160235801A1 (en) | 2016-08-18 |
EP3148351B1 (en) | 2022-03-30 |
CN106659200B (zh) | 2021-03-12 |
ES2914673T3 (es) | 2022-06-15 |
CA2950113A1 (en) | 2015-12-10 |
WO2015187120A1 (en) | 2015-12-10 |
MX2016015848A (es) | 2017-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Patrakar et al. | Phytochemical and pharmacological review on Laurus nobilis | |
Patel | Hibiscus sabdariffa: An ideal yet under-exploited candidate for nutraceutical applications | |
Salehi et al. | Apium plants: Beyond simple food and phytopharmacological applications | |
CN101779710B (zh) | 具有三降作用的苦丁袋茶及其制作方法 | |
KR100913243B1 (ko) | 숙취해소용 음료 조성물 | |
Malhotra | Fennel and fennel seed | |
Arawande et al. | Nutritional and phytochemical compositions of fireweed (Crassocephalum crepidioides). | |
Bahmani et al. | Pharmaceutical, phytochemical, and economical potentials of Glycyrrhiza glabra L: a review | |
JP6444434B2 (ja) | フィトケミカル強化水 | |
Rehman et al. | Commercial importance, medicinal value and therapeutic potentials of chaff flower (Achyranthes aspera)–a review | |
Ravindran et al. | Other herbs and spices: achiote to Szechuan pepper | |
JP6913685B2 (ja) | 経口投与用の解毒組成物及びその調製方法 | |
KR102136053B1 (ko) | 허브추출물을 유효성분으로 하는 숙취해소용 조성물 및 이를 함유하는 음료 | |
Zafar et al. | Fennel | |
Ajuru et al. | Qualitative and quantitative phytochemical screening of some species of Lamiaceae in Rivers State, Nigeria | |
Qasem | The Coloured Atlas of Medicinal and Aromatic Plants of Jordan and Their Uses (Volume Three) | |
Stojkovic et al. | Root vegetables as a source of biologically active agents-lesson from soil | |
Vekiari et al. | An overview of the wild plants consumed in the island of Crete, Greece | |
Ilyina et al. | Alimentary and medicinal plants in functional nutrition | |
Suse et al. | Development of healthy chocolate coated coconut balls by using herbal powders | |
Seher et al. | Chirayita | |
KR102651713B1 (ko) | 헛개나무 열매 및 녹용을 포함하는 숙취해소용 초콜릿 조성물 및 이를 이용하는 숙취해소용 초콜릿의 제조방법 | |
Cvetanović et al. | Medicinal Plants from the Balkan Peninsula—From Traditional To Modern Pharmacy/Medicine | |
Hanif | Asma Seher, Muhammad Asif Hanif | |
Adenowo et al. | Antioxidant Agents from Green Leafy Vegetables: A Review |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170512 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20180314 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180322 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180529 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20181101 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20181127 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6444434 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |